PBM supply chain intelligence for Psyence Biomedical Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Psyence Biomedical Ltd. (PBM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| FILAMENT | FILAMENT | 92% | Filament has undertaken to support Psyence’s clinical trial efforts through the supply of the required quantities of PEX010 to Psyence, for no additional charge, based on Psyence’s good faith forecas… |
| OPTIMI | OPTIMI | 90% | Psyence has successfully negotiated and executed supply agreements and licensing agreements for the use of third-party intellectual property with two licensed suppliers operating in the United Kingdo… |
| PSYLABS | PSYLABS | 90% | Psyence has successfully negotiated and executed supply agreements and licensing agreements for the use of third-party intellectual property with two licensed suppliers operating in the United Kingdo… |
| LPAA | Launch One Acquisition Corp. | 72% | Reciprocal relationship from LPAA graph: Reciprocal relationship from PBM graph: Reciprocal relationship from LPAA graph: tmouth College and a M.B.A. from the Kellogg Graduate School of Management at… |
| LPCV | Launchpad Cadenza Acquisition Corp I | 72% | Reciprocal relationship from LPCV graph: Reciprocal relationship from PBM graph: Reciprocal relationship from LPCV graph: ring in October 2024 and is currently searching for a Business Combination ta… |
| PBMWW | PBMWW | 72% | Reciprocal relationship from PBMWW graph: Reciprocal relationship from PBM graph: Reciprocal relationship from PBMWW graph: Reciprocal relationship from PBM graph: Reciprocal relationship from PBMWW … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| FILAMENT-HEALTH-CORP | FILAMENT-HEALTH-CORP | 85% | ical trials related to Psyence’s proposed products or the therapeutic areas in which Psyence’s proposed products will compete could have a material adverse effect on Psyence’s business, prospects, fi… |
| CGC | Canopy Growth Corporation | 72% | nabis. Daddy Cann Lesotho (Pty) Limited was subsequently acquired by Canopy Growth Corporation in May 2018. In 2000, Mr. Aufrichtig co-founded Indigo Properties, a business focused on commercial and … |
| CGC | Canopy Growth Corporation | 72% | Reciprocal relationship from CGC graph: Reciprocal relationship from PBM graph: Reciprocal relationship from CGC graph: Reciprocal relationship from PBM graph: Reciprocal relationship from CGC graph:… |
| AUSTRALIA-FOR-PSYENCE-AUSTRALIA-PTY-LTD | AUSTRALIA-FOR-PSYENCE-AUSTRALIA-PTY-LTD | 62% | license the use, development and commercialization rights to our product candidates or technology from third parties or, in certain cases, we fail to meet certain development deadlines, we could lose… |
| COMPANY-NEWCOURT-ACQUISITION-CORP | COMPANY-NEWCOURT-ACQUISITION-CORP | 62% | the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| NASDAQ-STOCK-MARKET-LLC | NASDAQ-STOCK-MARKET-LLC | 62% | manufacturing or selling our product candidates. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than us or the third parties from whom we licen… |
| NEWCOURT-SPAC-SPONSOR-LLC | NEWCOURT-SPAC-SPONSOR-LLC | 62% | the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| PASSIVE-FOREIGN-INVESTMENT-COMPANY | PASSIVE-FOREIGN-INVESTMENT-COMPANY | 62% | the Common Shares may be volatile and could decline significantly. The stock markets, including Nasdaq, on which the Company lists its securities, have from time to time experienced significant price… |
| PSILOCYBIN-ENHANCED-GROUP | PSILOCYBIN-ENHANCED-GROUP | 62% | ase of Psyence’s activities, specifically phase II clinical trials which, at present, consists of the Phase IIb Study. The license is granted on an exclusive basis solely within the territory of the … |
| SECOND-PSILOCYBIN-GROUP | SECOND-PSILOCYBIN-GROUP | 62% | ase of Psyence’s activities, specifically phase II clinical trials which, at present, consists of the Phase IIb Study. The license is granted on an exclusive basis solely within the territory of the … |
| SOUTHERN-STAR-RESEARCH-PTY-LTD | SOUTHERN-STAR-RESEARCH-PTY-LTD | 62% | ical trials related to Psyence’s proposed products or the therapeutic areas in which Psyence’s proposed products will compete could have a material adverse effect on Psyence’s business, prospects, fi… |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| PBM-OWNER-PARALLEL-ADVISORS-LLC | Parallel Advisors, LLC | 90% | 13F overlay lists Parallel Advisors, LLC as top holder; 5 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| LPAA | Launch One Acquisition Corp. | 100.00 | 1 | ['supplier'] |
| CBOE | Cboe Global Markets, Inc. | 100.00 | 2 | |
| LPCV | Launchpad Cadenza Acquisition Corp I | 100.00 | 1 | ['supplier'] |
| CGC | Canopy Growth Corporation | 100.00 | 1 | ['customer'] |
| PBMWW | PSYENCE BIOMEDICAL LTD. | 100.00 | 1 | ['supplier'] |
| INCR | InterCure Ltd. | 100.00 | 2 | |
| DB | Deutsche Bank Aktiengesellschaft | 50.00 | 2 | |
| FHI | Federated Hermes, Inc. | 50.00 | 2 | |
| CANTOR | CANTOR | 50.00 | 2 | |
| AKO-B | ANDINA BOTTLING CO INC | 50.00 | 2 | |
| GULTU | Gulf Coast Ultra Deep Royalty Trust | 50.00 | 2 | |
| AEG | Aegon Ltd. | 50.00 | 2 | |
| ECTM | ECA Marcellus Trust I | 50.00 | 2 | |
| CERO | CERo Therapeutics Holdings, Inc. | 50.00 | 2 | |
| IMXI | International Money Express, Inc. | 50.00 | 2 | |
| LIEN | Chicago Atlantic BDC, Inc. | 50.00 | 2 | |
| WENNW | Wen Acquisition Corp. | 50.00 | 2 | |
| VAC | Marriott Vacations Worldwide Corporation | 50.00 | 2 | |
| WT | WisdomTree, Inc. | 50.00 | 2 | |
| AKO-A | Embotelladora Andina S.A. | 50.00 | 2 |